Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Asante partners with Western University of Health Sciences to launch core rotation sites for medical students
Asante has partnered with Western University of Health Sciences’ COMP-Northwest to establish…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Sheikh Mohammed approves new Emirates Health Services Board
His Highness Sheikh Mohammed bin Rashid Al Maktoum has approved the reconstitution…
National Reference Laboratory Unveils Next-Generation AI Prostate Cancer Diagnostic Solution in the UAE
The National Reference Laboratory (NRL) has announced a significant advancement in cancer…
SEHA New Corniche Hospital for Women and Newborns Breaks Ground Under Pure Health
PureHealth has announced a major milestone in the development of Abu Dhabi’s…
Everest Medicines Secures LNZ100 Deal in Greater China
Everest Medicines has signed an Asset Purchase Agreement with Corxel Pharmaceuticals to…
Science&Humans Partners with Segic to Expand Access to Specialized Hormone Health Benefits
As employers face growing demand for more personalized healthcare solutions, Science&Humans, Canada's…
PureHealth performs GCC’s first separation of craniopagus twins’ procedure in Abu Dhabi
Abu Dhabi has successfully hosted the surgical separation of 15-month-old Nigerian conjoined…
